J, T., S, P., DA, B., P, S., G, S., AB, N., . . . N, U. (2026). Multimodal molecular testing provides prognostic value for heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 45(3), 388. https://doi.org/10.1016/j.healun.2025.11.013
Chicago Style (17th ed.) CitationJ, Teuteberg, et al. "Multimodal Molecular Testing Provides Prognostic Value for Heart Transplant Recipients." The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation 45, no. 3 (2026): 388. https://doi.org/10.1016/j.healun.2025.11.013.
MLA (9th ed.) CitationJ, Teuteberg, et al. "Multimodal Molecular Testing Provides Prognostic Value for Heart Transplant Recipients." The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, vol. 45, no. 3, 2026, p. 388, https://doi.org/10.1016/j.healun.2025.11.013.